{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.46",
    "chg": -0.01,
    "chgp": "-2.13%",
    "dir": -1,
    "prev_price": "0.47",
    "mcapval": "26.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE560F01022",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "5.42 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 2,
    "sid": "233635",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June 2026.",
      "datetime": "08-Aug-2026",
      "details": "Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve To consider and approve the Un-Audited (Standalone) Financial Results of the Company for the Quarter ended on 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jul-2026",
      "details": "Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended on 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News